Literature DB >> 6264030

Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in rats.

M Fekete, T Kádár, B Penke, K Kovács, G Telegdy.   

Abstract

The effects of intracerebroventricular administration of an 80 pmole dose of cholecystokinin octapeptide sulfate ester (CCK-8-SE) were tested on the dopamine (DA), norepinephrine (NE) and serotonin (5-HT) turnovers of the hypothalamus, mesencephalon, amygdala, septum, striatum and cerebral cortex in rats. CCK-8-SE in an 80 pmole dose decreased the DA turnovers of the hypothalamus, mesencephalon, amygdala and septum, while it increased that of the striatum. The NE turnovers were increased in the hypothalamus and amygdala, but decreased in the striatum. The 5-HT turnover decreased only in the hypothalamus.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6264030     DOI： 10.1007/bf01249131

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  21 in total

Review 1.  Peptides with a dual function: central neuroregulators and gut hormones.

Authors:  J M Loonen; W Soudijn
Journal:  J Physiol (Paris)       Date:  1979

2.  Cholecystokinin both stimulates and inhibits human food intake.

Authors:  R A Sturdevant; H Goetz
Journal:  Nature       Date:  1976-06-24       Impact factor: 49.962

Review 3.  Comparative biochemistry and physiology of gut hormones.

Authors:  G J Dockray
Journal:  Annu Rev Physiol       Date:  1979       Impact factor: 19.318

4.  Distribution of gastrin and CCK-like peptides in rat brain. An immunocytochemical study.

Authors:  I Lorén; J Alumets; R Håkanson; F Sundler
Journal:  Histochemistry       Date:  1979-02-21

5.  Structure-activity relationship of some analogues of gastrin and cholecystokinin on intestinal smooth muscle of the guinea-pig.

Authors:  E S Vizi; G Bertaccini; M Impicciatore; P Mantovani; J Zséli; J Knoll
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Cholecystokinin decreases food intake in rats.

Authors:  J Gibbs; R C Young; G P Smith
Journal:  J Comp Physiol Psychol       Date:  1973-09

7.  Evidence that acetylcholine released by gastrin and related polypeptides contributes to their effect on gastrointestinal motility.

Authors:  S E Vizi; G Bertaccini; M Impicciatore; J Knoll
Journal:  Gastroenterology       Date:  1973-02       Impact factor: 22.682

8.  Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.

Authors:  H G Baumgarten; A Björklund; L Lachenmayer; A Nobin; U Stenevi
Journal:  Acta Physiol Scand Suppl       Date:  1971

9.  Cholecystokinin-converting enzymes in brain.

Authors:  A Malesci; E Straus; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Cholecystokinin and its COOH-terminal octapeptide in the pig brain.

Authors:  J E Muller; E Straus; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205
View more
  5 in total

1.  Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia.

Authors:  E Peselow; B Angrist; A Sudilovsky; J Corwin; J Siekierski; F Trent; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Regional changes in neuropeptide levels after 5,7-dihydroxytryptamine-induced serotonin depletion in the rat brain.

Authors:  Y Kondo; N Ogawa; M Asanuma; H Hirata; K Tanaka; Y Kawada; A Mori
Journal:  J Neural Transm Gen Sect       Date:  1993

3.  Effects of ketamine on the cholecystokinin, somatostatin, substance P, and thyrotropin releasing hormone in discrete regions of rat brain.

Authors:  K Pongdhana; N Ogawa; Y Hirose; T Ono; F Kosaka; A Mori
Journal:  Neurochem Res       Date:  1987-01       Impact factor: 3.996

4.  Cell-Cell Communication Alterations via Intercellular Signaling Pathways in Substantia Nigra of Parkinson's Disease.

Authors:  Maoxin Huang; Liang Xu; Jin Liu; Pei Huang; Yuyan Tan; Shengdi Chen
Journal:  Front Aging Neurosci       Date:  2022-02-25       Impact factor: 5.750

Review 5.  Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Authors:  Santiago J Ballaz; Michel Bourin
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.